Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization

被引:35
作者
Coenjaerts, FEJ
Walenkamp, AME
Mwinzi, PN
Scharringa, J
Dekker, HAT
van Strijp, JAG
Cherniak, R
Hoepelman, AIM
机构
[1] Univ Med Ctr, Dept Med, Div Infect Dis & AIDS, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr, Eijkman Winkler Lab, NL-3508 GA Utrecht, Netherlands
[3] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA
关键词
D O I
10.4049/jimmunol.167.7.3988
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryptococcal capsular Ags induce the production of proinflammatory cytokines in patients with cryptococcal meningitis. Despite this, their cerebrospinal fluid typically contains few neutrophils. Capsular glucuronoxylomannan is generally considered to mediate the inhibition of neutrophil extravasation. In the current study, culture supernatant harvested from the nonglucuronoxylomannan-producing strain CAP67 was found to be as potent as supernatant from wild-type strains in preventing migration. We identified capsular mannoprotein (MP)-4 as the causative agent. Purified MP-4 inhibited migration of neutrophils toward platelet-activating factor, IL-8, and fMLP, probably via a mechanism involving chemoattractant receptor cross-desensitization, as suggested by its direct chemotactic activity. Supporting this hypothesis, MP-4 elicited Ca2+ transients that were inhibited by preincubation with either fMLP, IL-8, or C5a, but not platelet-activating factor, and vice versa. Moreover, MP-4 strongly decreased the neutrophil surface expression of L-selectin and induced shedding of TNF receptors p55/p75, whereas CD11b/18 increased. Finally, MP-4 was clearly detectable in both serum and cerebrospinal fluid of patients suffering from cryptococcal meningitis. These findings identify MP-4 as a novel capsular Ag prematurely activating neutrophils and desensitizing them toward a chemoattractant challenge.
引用
收藏
页码:3988 / 3995
页数:8
相关论文
共 48 条
[1]   ROLE OF TUMOR-NECROSIS-FACTOR AND GAMMA-INTERFERON IN ACQUIRED-RESISTANCE TO CRYPTOCOCCUS-NEOFORMANS IN THE CENTRAL-NERVOUS-SYSTEM OF MICE [J].
AGUIRRE, K ;
HAVELL, EA ;
GIBSON, GW ;
JOHNSON, LL .
INFECTION AND IMMUNITY, 1995, 63 (05) :1725-1731
[2]  
ALI H, 1994, J BIOL CHEM, V269, P24557
[3]  
AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139
[4]   Inflammatory mediators and stroke: New opportunities for novel therapeutics [J].
Barone, FC ;
Feuerstein, GZ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) :819-834
[5]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[6]  
CARLOS TM, 1994, BLOOD, V84, P2068
[7]   Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mono-nuclear cells [J].
Chaka, W ;
Verheul, AFM ;
Vaishnav, VV ;
Cherniak, R ;
Scharringa, J ;
Verhoef, J ;
Snippe, H ;
Hoepelman, IM .
INFECTION AND IMMUNITY, 1997, 65 (01) :272-278
[8]  
Chaka W, 1997, J IMMUNOL, V159, P2979
[9]   Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: No leukocytosis despite high interleukin-8 levels [J].
Chaka, W ;
Heyderman, R ;
Gangaidzo, I ;
Robertson, V ;
Mason, P ;
Verhoef, J ;
Verheul, A ;
Hoepelman, AIM .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1633-1636
[10]   CYTOKINE ENHANCEMENT OF COMPLEMENT-DEPENDENT PHAGOCYTOSIS BY MACROPHAGES - SYNERGY OF TUMOR-NECROSIS-FACTOR-ALPHA AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR PHAGOCYTOSIS OF CRYPTOCOCCUS-NEOFORMANS [J].
COLLINS, HL ;
BANCROFT, GJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) :1447-1454